By the end of this chapter you'll be able to…

  • 1Derive a withdrawal syndrome from the intoxication picture
  • 2State which withdrawal syndromes are potentially fatal and why
  • 3Distinguish tolerance, withdrawal, dependence and harmful use
  • 4Separate physical dependence from addiction
  • 5Reconstruct the timeline of alcohol withdrawal
  • 6Distinguish alcoholic hallucinosis from delirium tremens
  • 7Manage delirium tremens and state its mortality
  • 8Recognise Wernicke encephalopathy without waiting for the full triad
  • 9Explain why thiamine precedes glucose
  • 10Distinguish Wernicke encephalopathy from Korsakoff syndrome
  • 11Compare disulfiram, acamprosate and naltrexone by mechanism
  • 12Recognise opioid overdose and use naloxone appropriately
  • 13Explain why detoxification alone increases overdose mortality
  • 14Justify opioid substitution therapy and compare methadone with buprenorphine
  • 15Distinguish stimulant intoxication from primary psychosis
  • 16Recognise inhalant misuse and its complications
  • 17Describe benzodiazepine dependence and safe withdrawal
  • 18List the medical consequences of alcohol that present to other specialties
  • 19State the Indian epidemiological picture and the treatment gap
  • 20Match intervention to stage of change and justify harm reduction
💡
Why this chapter matters in NEET PG
Substance misuse is usually taught drug by drug, which produces a long list that is easy to confuse under pressure. Two questions reduce it to a pattern: what does intoxication look like, and what does withdrawal look like, because withdrawal is almost always the mirror image of intoxication. One asymmetry then decides urgency and is counterintuitive: alcohol and benzodiazepine withdrawal can be fatal, while opioid withdrawal, though agonising, usually is not. The clinical stakes are immediate and the errors are stereotyped, including glucose given before thiamine, detoxification offered without maintenance in opioid dependence, and stimulant intoxication treated as a first episode of schizophrenia.

Substance Use Disorders

Substance misuse is usually taught drug by drug, which produces a long list that is easy to confuse under examination pressure.

Two questions reduce it to a pattern.

What does intoxication look like, and what does withdrawal look like? For almost every drug, withdrawal is the mirror image of intoxication. Opioids constrict pupils and cause constipation, so withdrawal dilates pupils and causes diarrhoea. Alcohol sedates, so withdrawal produces tremor, agitation and seizures. Once you know the acute effect, you can derive the withdrawal syndrome instead of memorising it.

Which withdrawals are dangerous? This is the asymmetry that decides management, and it is counterintuitive.

Alcohol and benzodiazepine withdrawal can be fatal. Opioid withdrawal is intensely unpleasant but is not usually life-threatening, despite being the withdrawal that patients and families fear most.

A third idea underpins treatment. Dependence is a chronic relapsing condition, not a moral failure or a single event, so relapse is a feature of the illness to be planned for rather than evidence that treatment has failed.

1. Defining the Terms

Tolerance is a reduced effect from the same dose, or the need for a higher dose for the same effect.

Withdrawal is a characteristic syndrome on stopping or reducing use.

Dependence combines these with impaired control, craving, salience of use over other activities, and continued use despite harm.

Harmful use is a pattern causing damage to physical or mental health without meeting criteria for dependence.

The distinction that matters clinically is between physical dependence and addiction. A patient on long-term opioids for cancer pain may be physically dependent without being addicted, since addiction requires compulsive use and loss of control rather than simply a withdrawal syndrome on stopping.

2. Alcohol

Alcohol accounts for more medical morbidity than all other drugs of misuse combined, and the questions cluster around withdrawal and around thiamine.

Withdrawal by timeline

Time after last drinkFeature
6 to 12 hoursTremor, sweating, anxiety, nausea
12 to 24 hoursAlcoholic hallucinosis, typically visual, with clear consciousness
24 to 48 hoursWithdrawal seizures, generalised tonic-clonic
48 to 72 hours and beyondDelirium tremens

Alcoholic hallucinosis occurs in clear consciousness, which distinguishes it from delirium tremens, where consciousness is clouded and orientation is lost.

Delirium tremens carries significant mortality even with treatment, and considerably more without. It presents with clouded consciousness, disorientation, marked autonomic overactivity, severe tremor and vivid hallucinations, characteristically visual and often of small animals.

Treatment is with benzodiazepines in adequate doses, guided by symptom severity rather than by fixed schedules, alongside fluids, electrolytes and thiamine.

Wernicke and Korsakoff

Wernicke encephalopathy is the acute, reversible thiamine deficiency syndrome, with the classic triad of confusion, ataxia and ophthalmoplegia.

The triad is present in a minority of cases, which is the point most often missed. Waiting for all three before treating is the reason the condition progresses.

Korsakoff syndrome is the chronic, largely irreversible consequence, with anterograde amnesia, confabulation and relatively preserved other cognitive functions.

Two prescribing rules follow, and both are examined.

Give thiamine before glucose. Administering glucose to a thiamine-deficient patient consumes the remaining thiamine in glycolysis and can precipitate Wernicke encephalopathy.

Treat on suspicion, parenterally. Oral thiamine is poorly absorbed in alcohol dependence, and the cost of treating unnecessarily is negligible against the cost of missing it.

Long-term management

Disulfiram works by aversion, inhibiting aldehyde dehydrogenase so that alcohol produces acetaldehyde accumulation with flushing, vomiting and headache. It requires motivation and supervision.

Acamprosate reduces craving by modulating glutamatergic transmission. Naltrexone, an opioid antagonist, reduces the rewarding effect of drinking and is useful for reducing heavy drinking.

3. Opioids

Intoxication produces pinpoint pupils, respiratory depression and reduced consciousness, and the triad is what identifies overdose.

Naloxone reverses it, and the practical caution is that its half-life is shorter than that of most opioids, so a patient who responds may deteriorate again as it wears off and requires observation or repeated dosing.

Withdrawal is the mirror image: dilated pupils, lacrimation, rhinorrhoea, yawning, piloerection, abdominal cramps, diarrhoea, muscle aches and intense craving.

It is not usually life-threatening, which matters because fear of withdrawal drives continued use and because withdrawal alone is a poor treatment target.

Why detoxification alone fails

Detoxification without maintenance treatment has high relapse rates and increases overdose risk, because tolerance falls during abstinence while the habitual dose does not change in the person's memory.

Opioid substitution therapy with methadone or buprenorphine is the evidence-based treatment, reducing illicit use, criminal activity, transmission of blood-borne viruses and, critically, mortality.

Buprenorphine is a partial agonist with a ceiling effect on respiratory depression, which makes it safer in overdose, but it can precipitate withdrawal if given while a full agonist is still occupying receptors.

4. Other Substances

SubstanceIntoxicationWithdrawal
CannabisConjunctival injection, tachycardia, increased appetite, altered time senseIrritability, insomnia, appetite loss, craving
StimulantsDilated pupils, tachycardia, hypertension, hyperthermia, psychosisHypersomnia, hyperphagia, dysphoria, "crash"
BenzodiazepinesSedation, ataxia, slurred speech, anterograde amnesiaAnxiety, insomnia, tremor, seizures
InhalantsEuphoria, disinhibition, then depression; perioral dermatitisMild, largely psychological
NicotineAlertnessIrritability, poor concentration, appetite increase, craving

Stimulant intoxication is the one that mimics psychiatric illness most closely, producing paranoid psychosis with tactile hallucinations that can be indistinguishable from schizophrenia except by history, urine testing and the time course of resolution.

Cannabis is examined for its association with psychosis, which is dose-related, stronger with early adolescent use and with high-potency preparations, and stronger in those with genetic vulnerability.

Inhalant misuse is a particular problem among street children in Indian cities, using correction fluid, adhesives and petrol, and it causes cardiac arrhythmia, renal tubular acidosis and irreversible neurological damage.

Benzodiazepine dependence

This deserves separating because it is usually iatrogenic and because the withdrawal is dangerous.

Dependence develops within weeks of regular use, and tolerance to the anxiolytic effect appears well before tolerance to the sedative effect, so patients escalate the dose to regain an effect that will not return.

Withdrawal mirrors alcohol withdrawal because the mechanism is the same, with anxiety, insomnia, tremor, perceptual disturbance, and seizures at the severe end. Long-acting agents produce a later and more prolonged syndrome than short-acting ones.

Withdrawal is managed by conversion to a long-acting agent such as diazepam and a slow taper, often over months rather than weeks, and abrupt cessation is unsafe.

The most useful preventive point is that the risk is created at the moment of prescribing, so short courses with a stated end date, and an explicit conversation about what the drug is and is not for, prevent the problem more effectively than any withdrawal protocol.

5. The Medical Consequences That Present Elsewhere

Substance-related disease reaches other specialties long before it reaches a psychiatrist, and recognising the pattern is what allows earlier intervention.

Alcohol

Hepatic disease progresses from steatosis, which is reversible, through alcoholic hepatitis to cirrhosis. A ratio of aspartate to alanine aminotransferase above two is characteristic, which is the reverse of most other liver disease.

Pancreatitis, both acute and chronic, is a leading alcohol-related surgical presentation in India, and chronic disease brings exocrine insufficiency and diabetes.

Cardiomyopathy, hypertension and atrial fibrillation are cardiac consequences, with "holiday heart" describing arrhythmia after a binge.

Peripheral neuropathy, cerebellar degeneration and central pontine myelinolysis complete the neurological list, the last being a consequence of correcting hyponatraemia too rapidly rather than of alcohol itself.

Fetal alcohol spectrum disorder produces growth restriction, characteristic facies with a smooth philtrum and thin upper lip, and neurodevelopmental impairment. No safe threshold in pregnancy has been established.

Injecting drug use

Blood-borne virus transmission of HIV, hepatitis B and hepatitis C is the dominant risk, alongside infective endocarditis characteristically affecting the tricuspid valve, deep vein thrombosis, abscess and cellulitis at injecting sites.

This is the biological argument for needle and syringe programmes, which reduce transmission without increasing injecting, and it is why harm reduction is a public health intervention rather than a concession.

Tobacco

Tobacco causes more deaths in India than any other substance, and smokeless forms dominate, driving the country's exceptionally high burden of oral cavity cancer alongside oral submucous fibrosis from areca nut.

Nicotine replacement, bupropion and varenicline all increase cessation rates, and brief advice from any clinician has a small but genuine effect that scales across a population.

The Indian picture

The National Survey on Extent and Pattern of Substance Use in India established the scale, and the ordering is worth carrying.

Alcohol is the most used psychoactive substance after tobacco, with a substantial proportion of users meeting criteria for harmful or dependent use. Cannabis follows, and opioid use in India is proportionally higher than global averages, with pharmaceutical opioids and heroin both contributing.

Two structural problems dominate service delivery. The treatment gap is very large, with only a small minority of people with dependence receiving any treatment, and it is widest for alcohol despite alcohol causing the greatest burden.

Stigma keeps families from seeking help early, and the same stigma leads to treatment being sought in crisis rather than in the long maintenance phase where it works best.

Opioid substitution therapy is delivered through government programmes alongside the National Drug Dependence Treatment Centre network, and expansion of these services rather than the invention of new treatments is the principal lever available.

6. Assessment and Treatment Principles

Screening

CAGE asks about attempts to Cut down, Annoyance at criticism, Guilt about drinking and the need for an Eye-opener. AUDIT is more sensitive and detects hazardous drinking rather than only dependence.

Screening should be routine rather than triggered by suspicion, because the patients who look least likely are often those in whom detection changes most.

The stages of change

Precontemplation, contemplation, preparation, action, maintenance and relapse.

The value of the model is that it matches the intervention to the stage. Giving advice about stopping to a patient in precontemplation produces resistance, whereas exploring ambivalence moves them forward. Motivational interviewing works by resolving ambivalence rather than by supplying information the patient already has.

Relapse is included in the model deliberately, because it is the expected course of a chronic relapsing condition and not a failure of the patient or the treatment.

Harm reduction

Needle and syringe programmes, opioid substitution therapy, supervised consumption and naloxone distribution reduce mortality and blood-borne virus transmission.

The underlying principle is that reducing harm in someone still using is a legitimate goal, and that insisting on abstinence as a precondition for care excludes the people at highest risk.

India's National Mental Health Programme and the National Drug Dependence Treatment Centre framework support these approaches, and opioid substitution therapy is delivered through government programmes.

7. Worked Examples

Example 1. A man admitted after a fall becomes tremulous and anxious 10 hours later, then has a generalised seizure at 30 hours and by day three is disoriented, sweating profusely and seeing insects on the walls. Explain the sequence.

This is the standard timeline of alcohol withdrawal, and each stage is predictable from the last drink.

Tremor, sweating and anxiety at 6 to 12 hours reflect the loss of alcohol's positive modulation at GABA-A receptors, leaving an unopposed excitatory state. Withdrawal seizures characteristically occur at 24 to 48 hours. Delirium tremens follows at 48 to 72 hours or later, with clouded consciousness, disorientation, marked autonomic overactivity and vivid visual hallucinations, classically of small animals.

The distinction from alcoholic hallucinosis matters: that occurs earlier, at 12 to 24 hours, and crucially in clear consciousness with preserved orientation.

Management is benzodiazepines titrated to symptom severity, fluids and electrolytes, and parenteral thiamine. Delirium tremens carries significant mortality even with treatment, so this is an admission requiring close monitoring rather than a ward problem.

Example 2. A malnourished man with alcohol dependence is brought unconscious. The intern sets up an intravenous dextrose infusion. Comment.

Thiamine should be given before glucose.

Thiamine is a cofactor for pyruvate dehydrogenase and transketolase, both central to glucose metabolism. Administering a glucose load to a thiamine-depleted patient consumes the small remaining thiamine reserve in glycolysis, and this can precipitate or worsen Wernicke encephalopathy.

Wernicke encephalopathy classically presents with confusion, ataxia and ophthalmoplegia, but the complete triad is present in only a minority of cases, so waiting for it before treating is the commonest reason the condition is missed and allowed to progress to the largely irreversible Korsakoff syndrome.

Thiamine is given parenterally because oral absorption is unreliable in alcohol dependence, and it is given on suspicion rather than on confirmation, since the risk of treatment is negligible against the cost of missing it.

Example 3. A patient dependent on heroin completes a 10-day inpatient detoxification and is discharged abstinent. Two weeks later he dies of an overdose after using his usual amount. Explain.

Loss of tolerance is what killed him.

Chronic opioid use produces marked tolerance to respiratory depression, so a habitual user can survive doses that would be fatal to a naive person. Abstinence reverses that tolerance within days to weeks, but it does not change the dose the person remembers as normal. On relapse, the familiar amount is now an overdose.

This is why the period immediately after detoxification, after prison release and after hospital discharge carries the highest overdose mortality in this population, and why detoxification alone is not merely ineffective but actively raises risk.

The evidence-based alternative is opioid substitution therapy with methadone or buprenorphine, which reduces illicit use, blood-borne virus transmission and, most importantly, mortality. Take-home naloxone with training for the patient and family is a further specific intervention.

Example 4. A 24-year-old is brought agitated and paranoid, convinced insects are crawling under his skin. Pupils are dilated, he is tachycardic, hypertensive and febrile. How do you approach this?

This picture suggests stimulant intoxication, with amphetamine or cocaine the likely agents.

Several features separate it from a primary psychotic illness. The sympathomimetic signs of mydriasis, tachycardia, hypertension and hyperthermia are not features of schizophrenia. Tactile hallucinations, particularly formication, are characteristic of stimulant use. And the onset is acute rather than developing over weeks.

Assessment includes urine toxicology, temperature and cardiovascular monitoring, creatine kinase for rhabdomyolysis, and an electrocardiogram, while considering hyponatraemia and intracranial haemorrhage.

Management is supportive with benzodiazepines as first-line for agitation, active cooling for hyperthermia and fluids. Antipsychotics are used cautiously since they lower the seizure threshold and impair thermoregulation. The confirming feature is resolution over hours to days, which distinguishes it from a primary psychosis.

Example 5. A patient with alcohol dependence says he knows he drinks too much but has no intention of stopping. The doctor gives him a leaflet about liver damage and advises him to stop. Comment.

The intervention is mismatched to the stage.

He is in contemplation, aware of the problem but ambivalent about change, and information about harm is unlikely to add anything he does not already know. Direct advice to stop typically produces the patient defending his drinking, which strengthens rather than weakens his commitment to it.

Motivational interviewing works differently. It explores ambivalence rather than resolving it for the patient, elicits from him the reasons for change rather than supplying them, avoids argument, and lets him articulate the discrepancy between his drinking and his own goals.

The stages of change model matters because it matches intervention to readiness. It also normalises relapse as part of a chronic relapsing condition rather than as evidence of failure, which affects both how the patient is treated and whether he returns.

Summary

Withdrawal is usually the mirror image of intoxication.

Alcohol and benzodiazepine withdrawal can be fatal; opioid withdrawal usually is not.

Dependence is a chronic relapsing condition, so relapse is planned for rather than treated as failure.

Physical dependence is not the same as addiction.

Alcohol withdrawal: tremor at 6 to 12 hours, hallucinosis at 12 to 24, seizures at 24 to 48, delirium tremens after 48.

Alcoholic hallucinosis occurs in clear consciousness; delirium tremens does not.

Delirium tremens carries significant mortality even when treated.

Wernicke encephalopathy is confusion, ataxia and ophthalmoplegia, but the full triad is uncommon.

Give thiamine before glucose, parenterally, and on suspicion.

Korsakoff syndrome is anterograde amnesia with confabulation and is largely irreversible.

Disulfiram works by aversion; acamprosate and naltrexone reduce craving and reward.

Opioid overdose is pinpoint pupils, respiratory depression and reduced consciousness.

Naloxone has a shorter half-life than most opioids, so the patient must be observed.

Opioid withdrawal dilates pupils and causes diarrhoea, lacrimation and piloerection.

Detoxification alone raises overdose risk by reducing tolerance without changing the remembered dose.

Opioid substitution therapy reduces illicit use, viral transmission and mortality.

Buprenorphine has a ceiling on respiratory depression but can precipitate withdrawal.

Stimulant intoxication mimics psychosis but adds sympathomimetic signs and tactile hallucinations.

Inhalant misuse among street children causes arrhythmia, renal tubular acidosis and neurological damage.

Match the intervention to the stage of change, and treat harm reduction as a legitimate goal.

Key formulas & results

Everything to memorise for the exam hall, in one card. Screenshot this for revision.

The organising tool
WITHDRAWAL IS THE MIRROR IMAGE OF INTOXICATION. KNOW THE ACUTE EFFECT AND YOU CAN DERIVE THE WITHDRAWAL SYNDROME.
OPIOIDS CONSTRICT PUPILS AND CAUSE CONSTIPATION, SO WITHDRAWAL DILATES PUPILS AND CAUSES DIARRHOEA. ALCOHOL SEDATES, SO WITHDRAWAL PRODUCES TREMOR, AGITATION AND SEIZURES.
The asymmetry that decides urgency
ALCOHOL AND BENZODIAZEPINE WITHDRAWAL CAN BE FATAL. OPIOID WITHDRAWAL IS INTENSELY UNPLEASANT BUT NOT USUALLY LIFE-THREATENING.
THIS IS COUNTERINTUITIVE, SINCE OPIOID WITHDRAWAL IS THE ONE PATIENTS AND FAMILIES FEAR MOST, AND IT DETERMINES WHO NEEDS MEDICALLY SUPERVISED DETOXIFICATION.
Dependence is chronic and relapsing
RELAPSE IS A FEATURE OF THE ILLNESS TO BE PLANNED FOR, NOT EVIDENCE THAT TREATMENT HAS FAILED.
THIS FRAMING CHANGES BOTH WHAT IS OFFERED AND WHETHER THE PATIENT RETURNS AFTER A LAPSE, WHICH IS ITSELF A DETERMINANT OF OUTCOME.
Dependence versus addiction
A PATIENT ON LONG-TERM OPIOIDS FOR CANCER PAIN MAY BE PHYSICALLY DEPENDENT WITHOUT BEING ADDICTED.
ADDICTION REQUIRES COMPULSIVE USE AND LOSS OF CONTROL, NOT SIMPLY A WITHDRAWAL SYNDROME ON STOPPING. CONFUSING THE TWO LEADS TO UNDERTREATMENT OF PAIN.
The alcohol withdrawal timeline
6 TO 12 HOURS TREMOR AND SWEATING. 12 TO 24 HOURS ALCOHOLIC HALLUCINOSIS. 24 TO 48 HOURS WITHDRAWAL SEIZURES. 48 TO 72 HOURS AND BEYOND DELIRIUM TREMENS.
THE TIMELINE IS PREDICTABLE FROM THE LAST DRINK, WHICH MAKES IT BOTH A DIAGNOSTIC TOOL AND A BASIS FOR ANTICIPATORY MANAGEMENT.
Hallucinosis versus delirium tremens
ALCOHOLIC HALLUCINOSIS OCCURS IN CLEAR CONSCIOUSNESS WITH PRESERVED ORIENTATION. DELIRIUM TREMENS HAS CLOUDED CONSCIOUSNESS AND DISORIENTATION.
CONSCIOUSNESS IS THE DISCRIMINATOR, AND IT ALSO SEPARATES BOTH FROM PRIMARY PSYCHOSIS. DELIRIUM TREMENS CARRIES SIGNIFICANT MORTALITY EVEN WHEN TREATED.
Wernicke encephalopathy
CONFUSION, ATAXIA AND OPHTHALMOPLEGIA, BUT THE COMPLETE TRIAD IS PRESENT IN ONLY A MINORITY OF CASES.
WAITING FOR ALL THREE BEFORE TREATING IS THE COMMONEST REASON THE CONDITION IS MISSED AND ALLOWED TO PROGRESS TO KORSAKOFF SYNDROME.
Thiamine before glucose
THIAMINE IS A COFACTOR FOR PYRUVATE DEHYDROGENASE AND TRANSKETOLASE, SO A GLUCOSE LOAD CONSUMES REMAINING THIAMINE AND CAN PRECIPITATE WERNICKE ENCEPHALOPATHY.
GIVE IT PARENTERALLY, BECAUSE ORAL ABSORPTION IS UNRELIABLE IN ALCOHOL DEPENDENCE, AND GIVE IT ON SUSPICION RATHER THAN ON CONFIRMATION.
Korsakoff syndrome
ANTEROGRADE AMNESIA WITH CONFABULATION AND RELATIVELY PRESERVED OTHER COGNITIVE FUNCTIONS. LARGELY IRREVERSIBLE.
IT IS THE CHRONIC CONSEQUENCE OF UNTREATED OR UNDERTREATED WERNICKE ENCEPHALOPATHY, WHICH IS WHY THE ACUTE SYNDROME IS TREATED SO AGGRESSIVELY.
Three drugs for alcohol dependence
DISULFIRAM WORKS BY AVERSION THROUGH ALDEHYDE DEHYDROGENASE INHIBITION. ACAMPROSATE REDUCES CRAVING VIA GLUTAMATERGIC MODULATION. NALTREXONE BLOCKS THE REWARDING EFFECT OF DRINKING.
DISULFIRAM REQUIRES MOTIVATION AND SUPERVISION TO BE USEFUL, WHILE NALTREXONE IS PARTICULARLY USEFUL FOR REDUCING HEAVY DRINKING RATHER THAN ONLY FOR ABSTINENCE.
The opioid overdose triad
PINPOINT PUPILS, RESPIRATORY DEPRESSION AND REDUCED CONSCIOUSNESS.
NALOXONE REVERSES IT, BUT ITS HALF-LIFE IS SHORTER THAN THAT OF MOST OPIOIDS, SO A PATIENT WHO RESPONDS MAY DETERIORATE AGAIN AND REQUIRES OBSERVATION.
Opioid withdrawal
DILATED PUPILS, LACRIMATION, RHINORRHOEA, YAWNING, PILOERECTION, ABDOMINAL CRAMPS, DIARRHOEA, MUSCLE ACHES AND INTENSE CRAVING.
IT IS THE EXACT MIRROR OF INTOXICATION AND IS NOT USUALLY LIFE-THREATENING, WHICH MATTERS BECAUSE FEAR OF IT SUSTAINS CONTINUED USE.
Why detoxification alone is dangerous
TOLERANCE FALLS DURING ABSTINENCE WHILE THE HABITUAL DOSE DOES NOT CHANGE IN THE PERSON'S MEMORY, SO THE FAMILIAR AMOUNT BECOMES AN OVERDOSE ON RELAPSE.
THIS IS WHY OVERDOSE MORTALITY PEAKS AFTER DETOXIFICATION, AFTER PRISON RELEASE AND AFTER HOSPITAL DISCHARGE.
Opioid substitution therapy
METHADONE OR BUPRENORPHINE REDUCES ILLICIT USE, CRIMINAL ACTIVITY, BLOOD-BORNE VIRUS TRANSMISSION AND MORTALITY.
BUPRENORPHINE IS A PARTIAL AGONIST WITH A CEILING ON RESPIRATORY DEPRESSION, MAKING IT SAFER IN OVERDOSE, BUT IT CAN PRECIPITATE WITHDRAWAL IF GIVEN WHILE A FULL AGONIST IS STILL BOUND.
Stimulant intoxication
DILATED PUPILS, TACHYCARDIA, HYPERTENSION, HYPERTHERMIA AND PARANOID PSYCHOSIS WITH TACTILE HALLUCINATIONS.
THE SYMPATHOMIMETIC SIGNS AND THE FORMICATION SEPARATE IT FROM SCHIZOPHRENIA, AS DOES RESOLUTION OVER HOURS TO DAYS.
Inhalants in India
A PARTICULAR PROBLEM AMONG STREET CHILDREN USING CORRECTION FLUID, ADHESIVES AND PETROL.
COMPLICATIONS INCLUDE CARDIAC ARRHYTHMIA, RENAL TUBULAR ACIDOSIS AND IRREVERSIBLE NEUROLOGICAL DAMAGE, AND PERIORAL DERMATITIS IS A PHYSICAL CLUE.
Benzodiazepine dependence
DEVELOPS WITHIN WEEKS OF REGULAR USE. TOLERANCE TO THE ANXIOLYTIC EFFECT APPEARS BEFORE TOLERANCE TO SEDATION, SO PATIENTS ESCALATE TO REGAIN AN EFFECT THAT WILL NOT RETURN.
WITHDRAWAL IS MANAGED BY CONVERSION TO A LONG-ACTING AGENT AND A SLOW TAPER OVER MONTHS. THE RISK IS CREATED AT THE MOMENT OF PRESCRIBING.
The alcohol liver ratio
AN ASPARTATE TO ALANINE AMINOTRANSFERASE RATIO ABOVE TWO IS CHARACTERISTIC OF ALCOHOLIC LIVER DISEASE.
THIS IS THE REVERSE OF MOST OTHER LIVER DISEASE, WHICH MAKES IT A USEFUL POINTER ON ROUTINE BLOODS ORDERED FOR ANOTHER REASON.
Alcohol beyond the liver
PANCREATITIS, CARDIOMYOPATHY, HYPERTENSION, ATRIAL FIBRILLATION, PERIPHERAL NEUROPATHY AND CEREBELLAR DEGENERATION.
CENTRAL PONTINE MYELINOLYSIS IS A CONSEQUENCE OF CORRECTING HYPONATRAEMIA TOO RAPIDLY RATHER THAN OF ALCOHOL ITSELF, WHICH IS A COMMON MISATTRIBUTION.
Fetal alcohol spectrum disorder
GROWTH RESTRICTION, A SMOOTH PHILTRUM AND THIN UPPER LIP, AND NEURODEVELOPMENTAL IMPAIRMENT.
NO SAFE THRESHOLD IN PREGNANCY HAS BEEN ESTABLISHED, SO THE ADVICE IS ABSTINENCE RATHER THAN MODERATION.
Injecting risks
HIV, HEPATITIS B AND C TRANSMISSION, INFECTIVE ENDOCARDITIS CHARACTERISTICALLY OF THE TRICUSPID VALVE, DEEP VEIN THROMBOSIS, ABSCESS AND CELLULITIS.
THIS IS THE BIOLOGICAL ARGUMENT FOR NEEDLE AND SYRINGE PROGRAMMES, WHICH REDUCE TRANSMISSION WITHOUT INCREASING INJECTING.
Screening tools
CAGE ASKS ABOUT CUTTING DOWN, ANNOYANCE, GUILT AND EYE-OPENER. AUDIT IS MORE SENSITIVE AND DETECTS HAZARDOUS DRINKING RATHER THAN ONLY DEPENDENCE.
SCREENING SHOULD BE ROUTINE RATHER THAN TRIGGERED BY SUSPICION, BECAUSE THE PATIENTS WHO LOOK LEAST LIKELY ARE OFTEN THOSE IN WHOM DETECTION CHANGES MOST.
Stages of change
PRECONTEMPLATION, CONTEMPLATION, PREPARATION, ACTION, MAINTENANCE AND RELAPSE.
THE VALUE IS IN MATCHING INTERVENTION TO STAGE. ADVICE GIVEN IN PRECONTEMPLATION PRODUCES RESISTANCE, WHEREAS EXPLORING AMBIVALENCE MOVES THE PATIENT FORWARD.
Harm reduction
REDUCING HARM IN SOMEONE STILL USING IS A LEGITIMATE GOAL, AND INSISTING ON ABSTINENCE AS A PRECONDITION EXCLUDES THE PEOPLE AT HIGHEST RISK.
NEEDLE PROGRAMMES, SUBSTITUTION THERAPY, SUPERVISED CONSUMPTION AND TAKE-HOME NALOXONE ALL REDUCE MORTALITY AND VIRUS TRANSMISSION.
⚠️

Traps NEET PG sets — and how to dodge them

These are the exact option-traps and misreads that cost marks under negative marking.

WATCH OUT
Treating opioid withdrawal as the dangerous one
Alcohol and benzodiazepine withdrawal can cause seizures and death through unopposed excitation after GABA-A downregulation. Opioid withdrawal is severely distressing but rarely life-threatening, and this asymmetry determines who requires medically supervised detoxification.
WATCH OUT
Giving intravenous glucose before thiamine in a malnourished alcohol-dependent patient
Thiamine is a cofactor for pyruvate dehydrogenase and transketolase, so a glucose load consumes the last of a depleted reserve and can precipitate Wernicke encephalopathy. Parenteral thiamine is given first, and on suspicion rather than on confirmation.
WATCH OUT
Waiting for the full Wernicke triad before treating
Confusion, ataxia and ophthalmoplegia together are present in only a minority of cases, so requiring all three guarantees late treatment. The threshold for parenteral thiamine is any suspicion in a patient at risk, since the cost of overtreatment is negligible.
WATCH OUT
Confusing alcoholic hallucinosis with delirium tremens
Hallucinosis occurs at 12 to 24 hours in clear consciousness with preserved orientation, while delirium tremens occurs after 48 hours with clouded consciousness, disorientation and marked autonomic overactivity. Consciousness is the discriminator, and the second carries significant mortality.
WATCH OUT
Using fixed-schedule benzodiazepine regimens in alcohol withdrawal
Symptom-triggered dosing guided by severity gives better outcomes with lower total dose than fixed schedules, because withdrawal severity varies widely between patients. Fluids, electrolytes and thiamine accompany it in every case.
WATCH OUT
Offering opioid detoxification without maintenance treatment
Tolerance falls during abstinence while the remembered dose does not, so relapse after detoxification carries a markedly increased risk of fatal overdose. Substitution therapy with methadone or buprenorphine reduces mortality, which detoxification alone does not.
WATCH OUT
Discharging a patient after naloxone reverses their overdose
Naloxone has a shorter half-life than most opioids, particularly long-acting preparations, so the patient can re-sedate as it wears off. Observation for an appropriate period, or an infusion, is required rather than discharge on initial response.
WATCH OUT
Giving buprenorphine to a patient who has recently used a full agonist
As a high-affinity partial agonist it displaces the full agonist from receptors while producing less activation, precipitating an abrupt and severe withdrawal. Induction waits until objective withdrawal signs are present.
WATCH OUT
Diagnosing schizophrenia in an acutely paranoid young patient
Stimulant intoxication produces paranoid psychosis with tactile hallucinations alongside dilated pupils, tachycardia, hypertension and hyperthermia, none of which occur in schizophrenia. Urine toxicology and resolution over hours to days settle it.
WATCH OUT
Using antipsychotics as first-line for stimulant-induced agitation
Benzodiazepines are preferred because they treat agitation, lower sympathetic drive and reduce seizure risk, whereas antipsychotics lower the seizure threshold and impair thermoregulation in a patient who may already be hyperthermic.
WATCH OUT
Stopping benzodiazepines abruptly in a dependent patient
Withdrawal mirrors alcohol withdrawal because the mechanism is the same, with seizures at the severe end. Conversion to a long-acting agent such as diazepam followed by a slow taper over months is the safe approach.
WATCH OUT
Treating physical dependence on prescribed opioids as addiction
Physical dependence is an expected pharmacological consequence of sustained exposure, whereas addiction requires compulsive use, craving and loss of control despite harm. Conflating them leads to undertreated pain in patients with cancer.
WATCH OUT
Screening for alcohol only when the history suggests it
Routine screening with AUDIT or CAGE detects hazardous drinking in patients who do not fit the stereotype, and those are precisely the patients in whom brief intervention has the greatest effect. Selective screening reproduces the clinician's assumptions.
WATCH OUT
Giving advice about stopping to a patient in precontemplation
Direct advice at that stage produces resistance and strengthens the patient's arguments for continued use. Motivational interviewing explores ambivalence and elicits the patient's own reasons for change rather than supplying information they already possess.
WATCH OUT
Treating relapse as evidence that treatment has failed
Dependence is a chronic relapsing condition, and relapse is included in the stages of change model deliberately. Framing it as failure discourages re-engagement, which is itself one of the strongest determinants of eventual outcome.
WATCH OUT
Refusing care until the patient achieves abstinence
Harm reduction, including needle exchange, substitution therapy and take-home naloxone, reduces mortality and blood-borne virus transmission in people who continue to use. Abstinence as a precondition excludes those at highest risk from any care at all.

Exam-pattern practice

PYQ-style questions with full solutions. Work through them as a readiness check — mark yourself honestly and get your gap report at the end.

Readiness check

Are you exam-ready for "Substance Use Disorders"?

9 problems from this chapter. Try each one, reveal the worked solution, mark yourself honestly — get your gap report at the end.

9 questions~6 min

5-minute revision

The whole chapter, distilled. Read this the night before the exam.

  • Withdrawal is the mirror image of intoxication.
  • Alcohol and benzodiazepine withdrawal can be fatal.
  • Opioid withdrawal is unpleasant but rarely fatal.
  • Dependence is a chronic relapsing condition.
  • Physical dependence is not the same as addiction.
  • Alcohol withdrawal tremor begins at 6 to 12 hours.
  • Alcoholic hallucinosis occurs at 12 to 24 hours.
  • Hallucinosis occurs in clear consciousness.
  • Withdrawal seizures occur at 24 to 48 hours.
  • Delirium tremens occurs after 48 hours.
  • Delirium tremens has clouded consciousness and disorientation.
  • Delirium tremens carries significant mortality even when treated.
  • Symptom-triggered benzodiazepine dosing beats fixed schedules.
  • Wernicke encephalopathy is confusion, ataxia and ophthalmoplegia.
  • The full triad occurs in only a minority of cases.
  • Give thiamine before glucose.
  • Give thiamine parenterally and on suspicion.
  • Korsakoff syndrome is anterograde amnesia with confabulation.
  • Korsakoff syndrome is largely irreversible.
  • Disulfiram inhibits aldehyde dehydrogenase and works by aversion.
  • Acamprosate reduces craving through glutamatergic modulation.
  • Naltrexone blocks the rewarding effect of drinking.
  • Opioid overdose: pinpoint pupils, respiratory depression, reduced consciousness.
  • Naloxone has a shorter half-life than most opioids.
  • Observe or repeat dosing after naloxone response.
  • Opioid withdrawal dilates pupils and causes diarrhoea.
  • Detoxification alone increases overdose mortality.
  • Tolerance falls in abstinence while the remembered dose does not.
  • Substitution therapy reduces illicit use and mortality.
  • Buprenorphine has a ceiling on respiratory depression.
  • Buprenorphine can precipitate withdrawal if given too early.
  • Stimulant intoxication mimics psychosis with sympathomimetic signs.
  • Formication is characteristic of stimulant use.
  • Benzodiazepines are first-line for stimulant agitation.
  • Cannabis is associated with psychosis in a dose-related way.
  • Inhalant misuse affects street children in Indian cities.
  • Inhalants cause arrhythmia and renal tubular acidosis.
  • Benzodiazepine dependence develops within weeks.
  • Tolerance to anxiolysis precedes tolerance to sedation.
  • Convert to a long-acting agent and taper over months.
  • The dependence risk is created at the moment of prescribing.
  • An AST to ALT ratio above two suggests alcoholic liver disease.
  • Alcohol causes pancreatitis, cardiomyopathy and atrial fibrillation.
  • Holiday heart describes arrhythmia after a binge.
  • Central pontine myelinolysis follows rapid sodium correction.
  • Fetal alcohol spectrum disorder has no safe threshold.
  • Injecting risks include HIV, hepatitis and tricuspid endocarditis.
  • Needle programmes reduce transmission without increasing injecting.
  • Tobacco causes more Indian deaths than any other substance.
  • Smokeless tobacco drives India's oral cancer burden.
  • CAGE and AUDIT are screening tools, with AUDIT more sensitive.
  • Screening should be routine rather than suspicion-triggered.
  • Stages of change: precontemplation to maintenance and relapse.
  • Match the intervention to the stage.
  • Motivational interviewing resolves ambivalence rather than giving information.
  • Relapse is part of the model, not a failure.
  • Harm reduction in continued users is a legitimate goal.
  • Alcohol and cannabis follow tobacco in Indian prevalence.
  • Indian opioid use is proportionally higher than global averages.
  • The treatment gap is very large and widest for alcohol.

NEET PG question blueprint

How this topic is asked, tier by tier — so you can prep to the pattern.

Typical weightage: Each NEET PG question is worth +4/-1; substance use disorders contribute 5-7 questions per attempt and overlap with Medicine, Forensic Medicine and PSM

Question styleMarks eachTypical countWhat it tests
Alcohol withdrawal4~2The timeline, hallucinosis versus delirium tremens, and symptom-triggered treatment
Wernicke and Korsakoff4~1The incomplete triad, thiamine before glucose, and the chronic amnestic syndrome
Opioids4~1The overdose triad, naloxone half-life, and the withdrawal picture
Opioid treatment4~1Why detoxification alone raises mortality and the evidence for substitution therapy
Stimulants4~1Distinguishing stimulant psychosis from schizophrenia and choosing sedation
Benzodiazepines4~1Uneven tolerance, dangerous withdrawal and the tapering approach
Alcohol complications4~1Hepatic, pancreatic, cardiac and neurological consequences including osmotic demyelination
Harm reduction4~1Stages of change, motivational interviewing and the rationale for harm reduction

Exam-hall strategy

Battle-tested tips from mentors and toppers for this topic under the sectional clock.

  1. Derive the withdrawal picture by inverting the intoxication picture.
  2. For any withdrawal stem, check whether it is a GABAergic drug; those are the dangerous ones.
  3. Read the hours since the last drink; the alcohol timeline is examined directly.
  4. Check consciousness to separate hallucinosis from delirium tremens.
  5. In an unconscious alcohol-dependent patient, the answer involves thiamine first.
  6. For opioid stems, look for whether maintenance is offered rather than detoxification alone.
  7. Sympathomimetic signs with paranoia mean stimulants, not schizophrenia.
  8. With NEET PG's +4/-1 marking, the alcohol withdrawal timeline, the opioid triad and the thiamine rule are high-certainty recall worth banking early.
  9. Under the 5-group, 42-minute time-bound format, clear those fast and spend the remaining time on the treatment-principle and harm-reduction stems, since a closed group cannot be reopened.

Beyond the exam

Where this skill shows up in the job you're competing for — and in life.

Giving thiamine before hanging the dextrose

Reordering two steps in a resuscitation prevents an entirely iatrogenic Wernicke encephalopathy in a patient whose thiamine stores are already nearly gone.

Offering substitution rather than detoxification

Starting methadone or buprenorphine instead of a ten-day detoxification is the choice that reduces mortality, since detoxification alone strips tolerance and raises overdose risk on relapse.

Sending naloxone home with the patient

Training a family member to recognise pinpoint pupils and give naloxone turns the highest-risk weeks after discharge into a survivable period.

Screening everyone rather than the obvious

Routine AUDIT scoring finds hazardous drinking in patients who do not match the stereotype, and brief intervention at that stage changes far more than treatment offered after dependence.

Where else this topic is tested

Prepare once, score in every exam that asks it.

FMGE / NExTVery high overlap — alcohol withdrawal, Wernicke encephalopathy, opioid overdose and Indian epidemiology are examined at identical depth
USMLE Step 2 CKHigh overlap — withdrawal syndromes, naloxone, substitution therapy and screening tools are shared, with more emphasis on office-based buprenorphine
MD Psychiatry and DNB entranceFoundational — assumed working knowledge, with neurobiology of addiction, detoxification protocols and service models examined far more deeply

Questions aspirants ask

Pulled from the Q&A community and mentor sessions.

Because the two act on different systems, and only one of them is the brain's principal brake. Alcohol and benzodiazepines are positive modulators at the GABA-A receptor, the main inhibitory neurotransmitter system in the central nervous system. Sustained exposure produces adaptation in two directions: GABA-A receptors are downregulated and become less responsive, and excitatory glutamatergic transmission, particularly at NMDA receptors, is upregulated to compensate. As long as the drug is present the system is balanced. Remove it abruptly and the compensations remain while the inhibition disappears, leaving a profoundly hyperexcitable brain. The result is progressive: tremor and autonomic overactivity first, then hallucinations, then generalised seizures, then delirium tremens with clouded consciousness and cardiovascular collapse, which carries meaningful mortality even when treated in hospital. Opioid withdrawal has a different substrate. Mu receptor agonism is lost, and the dominant consequence is disinhibition of noradrenergic output from the locus coeruleus. That produces sweating, cramps, diarrhoea, piloerection, lacrimation and intense craving, which is genuinely agonising and drives people back to use, but it does not produce seizures or the cardiovascular instability that kills in alcohol withdrawal. The clinical consequence is that alcohol and benzodiazepine withdrawal require medically supervised detoxification, whereas opioid withdrawal is managed for comfort and, more importantly, for retention in treatment.

Because glucose metabolism consumes thiamine, and these patients have almost none left. Thiamine, as thiamine pyrophosphate, is an essential cofactor for several enzymes central to carbohydrate metabolism, most importantly pyruvate dehydrogenase, which converts pyruvate to acetyl-CoA, alpha-ketoglutarate dehydrogenase in the citric acid cycle, and transketolase in the pentose phosphate pathway. Alcohol dependence depletes thiamine through several routes at once: poor dietary intake, impaired absorption from the jejunum, reduced hepatic storage and increased requirement. Body stores last only two to three weeks. When a glucose load is given to such a patient, the sudden metabolic demand consumes whatever thiamine remains, and the cells most vulnerable are those in the mammillary bodies, periaqueductal grey and medial thalamus, which have high metabolic rates. The result is Wernicke encephalopathy, or an acute worsening of a subclinical case. The practical rules follow directly and are unambiguous. Thiamine goes in before or with the glucose, never after. It is given parenterally because absorption is unreliable in this population. And it is given on suspicion rather than on confirmation, because the diagnostic triad of confusion, ataxia and ophthalmoplegia is complete in only a minority, because untreated Wernicke encephalopathy progresses to irreversible Korsakoff syndrome, and because the risk of unnecessary thiamine is essentially nil.

Because it removes tolerance without removing the memory of a dose. Tolerance to opioids develops rapidly and is substantial, particularly for respiratory depression, so a person using regularly may tolerate a quantity many times the lethal dose for someone naive. That tolerance is a pharmacodynamic adaptation, and it declines quickly during abstinence, over days to a few weeks. What does not decline is the person's learned sense of what a normal dose is, and the environmental and social cues that drive relapse are entirely unchanged by a detoxification admission. The consequence is that a person who relapses after detoxification typically uses their previous amount, which their now-untolerant respiratory centre cannot survive. Studies consistently find peaks of overdose mortality in the weeks after detoxification, after release from prison and after discharge from hospital, all situations that produce enforced abstinence followed by return to a using environment. This is why detoxification without maintenance is regarded not merely as ineffective but as potentially harmful, and why opioid substitution therapy with methadone or buprenorphine is the evidence-based treatment: it maintains tolerance, occupies receptors, blunts craving and, uniquely among interventions for this condition, reduces mortality. Take-home naloxone with training for the person and their family addresses the same risk directly.

Because it withholds the intervention from the people it would help most, and because the evidence for that intervention does not depend on abstinence. Dependence is a chronic relapsing condition with a course more like diabetes or hypertension than like a curable infection, and continued use during treatment is part of that natural history. Requiring abstinence before offering care therefore selects out the most severely affected, who are also those at greatest risk of death, blood-borne virus transmission and social harm. The empirical case is stronger still. Opioid substitution therapy reduces illicit use, criminal activity, hepatitis and HIV transmission and mortality, and those benefits accumulate with time in treatment rather than requiring complete abstinence. Retention is the single strongest predictor of survival, so a policy of discharging patients who use will predictably increase deaths. Needle and syringe programmes reduce blood-borne virus transmission without increasing injecting, a finding that has been replicated repeatedly and that addresses the main objection raised against them. Take-home naloxone reduces overdose deaths. None of this makes abstinence unimportant; it remains a worthwhile goal for many patients and is achieved by some. But it functions as an outcome to work toward rather than as an entry requirement, and treating it as the latter converts a health service into a moral test.

Because tolerance develops unevenly across the drug's effects, and the effect they are chasing is the one that fades first. Benzodiazepines produce anxiolysis, sedation, muscle relaxation, anticonvulsant action and anterograde amnesia, all through positive modulation at GABA-A receptors. Tolerance to the anxiolytic and hypnotic effects develops within weeks of regular use, whereas tolerance to some other effects develops more slowly. The patient therefore notices that the dose which once settled their anxiety or produced sleep no longer does so, and the obvious response is to take more. The higher dose works briefly, tolerance follows again, and the cycle repeats while dependence deepens. A second process compounds it. As each dose wears off, rebound anxiety and rebound insomnia appear, and these are experienced as the original illness returning rather than as a drug effect, which powerfully reinforces continued use and makes the drug feel necessary. Both processes are pharmacological rather than characterological, which matters for how the patient is treated. Management is conversion to a long-acting agent such as diazepam to smooth plasma levels, then a slow taper measured in months, with explicit warning that symptoms will worsen transiently. Psychological treatment for the underlying problem runs alongside, since withdrawing the drug without addressing what it was prescribed for invites recurrence.
Header Logo